Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/21/7/1411/389963/mdp552.pdf
Reference18 articles.
1. Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making;Chao;J Clin Oncol,2003
2. Impact of presentation of research results on likelihood of prescribing medications to patients with left ventricular dysfunction;Lacy;Am J Cardiol,2001
3. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?;Naylor;Ann Intern Med,1992
4. Improving the quality of reporting of randomized controlled trials. The CONSORT statement;Begg;JAMA,1996
5. Reporting number needed to treat and absolute risk reduction in randomized controlled trials;Nuovo;JAMA,2002
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncology;The Lancet;2024-01
2. Current Scenario of Clinical Cancer Research in Latin America and the Caribbean;Current Oncology;2023-01-04
3. Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity;Current Oncology;2022-04-07
4. Evolution of the Randomized Clinical Trial in the Era of Precision Oncology;JAMA Oncology;2021-05-01
5. Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience;JNCI: Journal of the National Cancer Institute;2021-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3